Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02163902 · ClinicalTrials.gov registry record · Phase 3
Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101
A Phase 3 study of Healthy and Submental Fat, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 3
- Development phase
- 224
- Enrollment target
- 15
- Study locations
NCT02163902 is a Phase 3 study of Healthy and Submental Fat that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 224 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (65% lower). The trial reports 15 study locations across 8 states.
The verdict
NCT02163902, a Phase 3 study of Healthy and Submental Fat, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 224 participants
- Enrollment target
- 15
- Study locations
Study Summary
The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.
Conditions Studied
Interventions
- DRUG Placebo
- DRUG ATX-101
Study Locations (15)
Florida
- Dermatology Research Institute - Coral Gables
- Stephan Baker MD PA - Coral Gables
- Baumann Cosmetic and Research Center - Miami
- Kenneth R. Beer, MD, PA - West Palm Beach
Illinois
- Altman Dermatology Associates - Arlington Hts
- DeNova Research - Chicago
- DuPage Medical Group, Dermatology Institute - Naperville
Maryland
- Callender Center for Clinical Research - Glendale
- Aesthetics, Skin Care, Dermatologic Surgery - Rockville
Other
- Shannon Humphrey, MD - Vancouver
- Carruthers Dermatology Centre Inc. - Vancouver
California
- Dermatology Cosmetic Laser Medical Associates of La Jolla - San Diego
Colorado
- AboutSkin Dermatology and DermSurgery, PC - Englewood
Tennessee
- Tennessee Clinical Research Center - Nashville
Texas
- Research Across America - Plano
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2013-12 |
| Est. Completion | 2016-08 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02163902
The ClinicalTrials.gov registry entry for NCT02163902 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (65% lower). The listed sponsor is Kythera Biopharmaceuticals, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02163902 reports 15 study locations spanning 8 distinct geographic areas - top geographies include Florida, Illinois, Maryland.
Frequently Asked Questions
What is clinical trial NCT02163902 about?
NCT02163902 is a clinical study titled "Long-term Follow-up Study on Safety and Maintenance of Efficacy of ATX-101". The investigation of the long-term safety and maintenance of efficacy of ATX-101 in reduction of submental fat.
What is the current status of trial NCT02163902?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 224 participants. The study started on 2013-12. Estimated completion is 2016-08.
What conditions does trial NCT02163902 study?
This clinical trial studies the following conditions: Healthy, Submental Fat.
What interventions are being tested in trial NCT02163902?
The interventions under investigation include: Placebo (DRUG), ATX-101 (DRUG).
Who is sponsoring clinical trial NCT02163902?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02163902 being conducted?
This trial has 15 study locations across California, Colorado, Florida, Illinois, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babies
RECRUITING · Phase 3
-
Filgrastim-Mobilized Stem Cells for Transplantation Using Unrelated Donors
RECRUITING · Phase 3
-
A Study to Evaluate the Effect of Genetic Variation on Beta-cell Function During Fasting and Hyperglycemia in Nondiabetics
COMPLETED · Phase 3
-
Study to Investigate the Potential of Probiotics in Yogurt
COMPLETED · Phase 3
-
Trial to Demonstrate Equivalent Immunogenicity of CAIV-T and FLUMIST in Healthy Participants
COMPLETED · Phase 3
-
Study to Evaluate the Safety of a Bivalent Vaccine of New 6:2 Influenza Virus Reassortants in Healthy Adults
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.